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Prognosis of Negative Adenosine Stress
agnetic Resonance in Patients Presenting
o an Emergency Department With Chest Pain
. Patricia Ingkanisorn, MD,* Raymond Y. Kwong, MD,* Nicole S. Bohme, BA,† Nancy L. Geller, PHD,†
enneth L. Rhoads, MD,* Christopher K. Dyke, MD,* D. Ian Paterson, MD,* Mushabbar A. Syed, MD,*
nthony H. Aletras, PHD,* Andrew E. Arai, MD*
ethesda, Maryland
OBJECTIVES This study was designed to determine the diagnostic value of adenosine cardiac magnetic
resonance (CMR) in troponin-negative patients with chest pain.
BACKGROUND We hypothesized that adenosine CMR could determine which troponin-negative patients
with chest pain in an emergency department have coronary artery disease (CAD) or future
adverse cardiac events.
METHODS Adenosine stress CMR was performed on 135 patients who presented to the emergency
department with chest pain and had acute myocardial infarction (MI) excluded by troponin-I.
The main study outcome was detecting any evidence of significant CAD. Patients were
contacted at one year to determine the incidence of significant CAD defined as coronary
artery stenosis 50% on angiography, abnormal correlative stress test, new MI, or death.
RESULTS Adenosine perfusion abnormalities had 100% sensitivity and 93% specificity as the single
most accurate component of the CMR examination. Both cardiac risk factors and CMR were
significant in Kaplan-Meier analysis (log-rank test, p 0.0006 and p 0.0001, respectively).
However, an abnormal CMR added significant prognostic value in predicting future diagnosis
of CAD, MI, or death over clinical risk factors. In receiver operator curve analysis, adenosine
CMR was a more accurate predictor than cardiac risk factors (p  0.002).
CONCLUSIONS In patients with chest pain who had MI excluded by troponin-I and non-diagnostic
electrocardiograms, an adenosine CMR examination predicted with high sensitivity and
specificity which patients had significant CAD during one-year follow-up. Furthermore, no
patients with a normal adenosine CMR study had a subsequent diagnosis of CAD or an
adverse outcome. (J Am Coll Cardiol 2006;47:1427–32) © 2006 by the American College
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.11.059of Cardiology Foundation
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in the U.S., over eight million patients present to emer-
ency departments annually with chest pain (1). Guidelines
y the American College of Cardiology and the American
eart Association provide a systematic approach to the
atient with possible acute coronary syndrome (2). The elec-
rocardiogram (ECG) is used to identify ST-segment elevation
yocardial infarction (MI) and initiate acute interventions.
iomarkers, particularly serum assays of troponin, identify a
roup of patients with significantly higher cardiovascular
isk. After excluding infarction, there remains the need to
etect significant coronary stenoses, because many cases of
nstable angina are not identified by the ECG and enzymes.
urthermore, 15% of patients with undiagnosed unstable
ngina will have an MI in the subsequent two months (3).
This study was designed to determine the diagnostic
alue of adenosine cardiac magnetic resonance (CMR) in
roponin-negative patients with chest pain. The main study
utcome attempted to provide clinical reassurance that a
iagnosis of important coronary artery disease (CAD) was
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005, accepted November 21, 2005.ot missed by adenosine stress CMR. Thus, a normal
denosine CMR would be considered false negative if any
linical evidence of CAD was detected over the year after
esting. As will be shown, an abnormal adenosine CMR
xamination had a high sensitivity and specificity in pre-
icting adverse cardiovascular outcomes, whereas a normal
denosine CMR examination predicted an excellent one-
ear prognosis.
ETHODS
tudy group. Patients were prospectively enrolled at a
ommunity hospital after giving informed consent (n 
41). Inclusion criteria required 30 min of chest discomfort
ompatible with myocardial ischemia, a negative troponin
6 h after the last episode of chest pain, and an ECG not
iagnostic of ST-segment elevation MI or ischemia (3-mm
-wave inversion or 1-mm ST-segment depression).
atients were imaged within 72 h of presentation. Exclusion
riteria were New York Heart Association functional class IV
ongestive heart failure, second- or third-degree atrioventric-
lar block, hemodynamic instability, history of asthma or
ronchospastic disease, and standard CMR contraindications,
ncluding cerebral aneurysm clips, metal in the eye, and
mplanted metallic devices.
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Prognostic Value of Negative Adenosine CMR April 4, 2006:1427–32ine CMR. The CMR was performed using a General
lectric (Waukesha, Wisconsin) CV/i 1.5-T scanner and a
our-element cardiac phased-array coil. Cine CMR was
erformed in multiple parallel short-axis planes, 8 mm
hick, separated by 3-mm gaps and in the two-chamber,
hree-chamber, and four-chamber long-axis views as previ-
usly described (4).
denosine perfusion CMR. Adenosine was administered
ntravenously at 140 g/kg/min over 6 min. Four minutes
nto the infusion, the method of Slavin et al. (5) was used to
mage the first pass of a bolus (0.1 mmol/kg at 5 ml/s) of
adolinium diethylenetriamine pentaacetic acid (Berlex,
ayne, New Jersey). Typically at least nine short-axis slices
ere acquired gated to every other heartbeat. The patients
ere monitored by ECG, noninvasive sphygmomanometry,
nd pulse oximetry.
elayed enhancement CMR. An inversion recovery fast
radient echo sequence triggered every other heartbeat (6,7)
as performed to assess for MI. Images were obtained
pproximately 20 min after net intravenous injection of 0.2
mol/kg gadolinium diethylenetriamine pentaacetic acid.
he in-plane image resolution was typically 2.5 mm (42
l/voxel). The infarct imaging planes reproduced the views
sed on the cine and perfusion images.
nalysis of CMR studies. An abnormal CMR study was
efined by the presence of either a regional wall motion
bnormality, a perfusion defect during adenosine infusion,
r evidence of delayed enhancement. Regional wall motion
bnormalities were primarily based upon the short-axis view
nd if possible, confirmed in an orthogonal long-axis view.
erfusion scans were interpreted qualitatively by consensus
f three cardiologists blinded to study end points. A
erfusion defect was defined as abnormal if it was definitely
arker than surrounding myocardium and if it persisted
ore than three images beyond initial peak enhancement of
he segment which appeared most normal. Delayed en-
ancement images were displayed with a gray scale to
ptimally show normal myocardium as dark and the regions
f delayed enhancement or fat as bright.
Left ventricular ejection fractions were calculated from
nd-diastolic and end-systolic endocardial tracings of mul-
iple parallel short-axis images using computer-assisted
lanimetry. Qualitative assessment of left ventricular wall
hickening was summarized using the 16-segment model of
Abbreviations and Acronyms
CAD  coronary artery disease
CMR  cardiac magnetic resonance
ECG  electrocardiogram
MI  myocardial infarction
TLCMR  total number of cardiac magnetic resonance
abnormalities
TLCRF  total number of cardiac risk factorshe American Society of Echocardiography (8). Irimary outcome. The main study outcome aimed at
nswering the clinical question in the emergency depart-
ent of whether important CAD was present in an indi-
idual patient with chest pain. This main composite adverse
utcome (9) was defined as interval diagnosis of 50%
tenosis on X-ray coronary angiography, abnormal correla-
ive stress nuclear imaging with findings consistent with the
MR scan, new MI, or death during one-year follow-up.
econdary analysis. We also analyzed whether chronic MI
ould explain apparent false positive perfusion scans based
n the presence or absence of delayed enhancement associ-
ted with the perfusion defect. Chronic MI was defined as
elayed enhancement consistent with MI in this study
roup where acute MI was excluded on the basis of serial
roponin-I, serial ECGs, and clinical evaluation.
tatistical methods. Sensitivity, specificity, positive pre-
ictive value, and negative predictive value in predicting an
dverse cardiovascular outcome were calculated for each
MR abnormality individually and any CMR abnormality.
Survival distributions for the time to event were esti-
ated using the Kaplan-Meier method (10). The differ-
nces between survival distributions were assessed using the
og-rank test (11).
Cox proportional hazards regression (12) was performed
o determine whether a CMR abnormality added significant
rognostic value over clinical risk factors in predicting the
ain study outcome. Because there was significant censor-
ng, Firth’s bias correction procedure (13) was used with the
AS macro developed by Heinze and Schemper (14).
ecause of the number of events, the analysis used the total
umber of cardiac risk factors at baseline (TLCRF), rather
han individual factors. The TLCRF ranged from 0 to 7,
nd was defined as the number of the following risk factors
15) that were present: hypertension, hyperlipidemia, dia-
etes mellitus, age 45 years for males or 55 years for
emales, current tobacco use, history of CAD (as defined by
nown prior MI or prior angiographically significant coro-
ary disease), and family history of CAD.
Receiver operating characteristic curves were generated
or TLCRF and the total number of CMR abnormalities
TLCMR). The TLCMR ranged from 0 to 3 and was
efined as the number of the following that were present:
egional wall motion abnormality, delayed enhancement, and
denosine perfusion abnormality. The areas under the curves
ere compared using the method of DeLong et al. (16).
ESULTS
f the 141 patients enrolled, 139 patients (99%) were
ollowed by telephone contact with the patient or a family
ember, communication with their primary care physicians,
nd/or medical record review. Of the two patients lost to
ollow-up, one was a 31-year-old man and the other was a
6-year-old man. Neither was reported as deceased when
ross-referenced against the Social Security Death Index
nteractive Search site. Four of the 141 patients had
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April 4, 2006:1427–32 Prognostic Value of Negative Adenosine CMRondiagnostic perfusion studies and were excluded from
nalysis but had no adverse events in long-term follow-up.
wo of the delayed enhancement studies were considered
on-diagnostic but were not considered reason to exclude
atients from analysis. Thus, final analysis was performed
n 135 patients. The baseline characteristics and cardiac risk
actors of the 135 study participants are shown in Table 1
verall and stratified by adverse cardiac outcome.
The median follow-up was 467 days (1.28 years). On
ollow-up, 20 patients experienced the composite study out-
ome (14.8%). Fifteen patients had angiographically significant
AD, two patients had an abnormal correlative stress nuclear
tudy, one patient had an MI, and two patients died. Eleven
atients underwent coronary revascularization; the remainder
ere treated with medical therapy based upon their cardiolo-
ists’ recommendations. As seen in Table 1, hypertension, age
s a risk factor, prior coronary revascularization, prior MI, and
rior history of CAD were significantly more prevalent in the
roup with the adverse composite outcome.
Table 1. Baseline Patient Characteristics
All Patients
(n  135)
Adv
Males 75 (56)
Hypertension 56 (42)
Diabetes mellitus 14 (10)
Hyperlipidemia 71 (53)
Tobacco use 40 (30)
Family history of CAD 61 (45)
Age as risk factor 88 (65)
History of PCI or CABG 16 (12)
History of MI 9 (7)
History of CAD 23 (17)
Age (yrs) 55.7  13.8
Total # of risk factors 2.6  1.6
Data are n (%) or mean  SD.
CABG  coronary artery bypass graft; CAD  coronary
coronary intervention.
igure 1. Examples of abnormal adenosine cardiac magnetic resonance stu
eri-infarct ischemia. The top row shows results from a 67-year-old female with
nd an inferoseptal to inferolateral perfusion defect (arrows).The bottom row s
raft surgery (h/o CABG), silent micro-inferior myocardial infarction (MI) (black
rrows). Both patients had significant coronary stenoses and required revascularizatMR results. There were no major complications related to
he adenosine stress testing. Adenosine was terminated
rematurely in four patients owing to symptoms, but per-
usion images were still obtained. One test was terminated
ecause of a panic attack after perfusion imaging, but there
ere no clinical sequelae.
Figure 1 (top row) demonstrates a perfusion defect in a
atient who had no prior CAD. Figure 1 (bottom row)
llustrates a case with abnormal resting regional wall motion
nd delayed enhancement despite no prior clinical history of
nfarction. However, the adenosine perfusion defect was
ore extensive than the region of infarction consistent with
stress-induced peri-infarct perfusion defect. Both patients
equired coronary revascularization.
The mean left ventricular ejection fraction was 65 
1%, and only five subjects had ejection fractions 45%.
ineteen patients had a regional wall motion abnormal-
ty. Twenty-eight patients had abnormal adenosine per-
usion.
Outcome
20)
No Adverse Outcome
(n  115) p Value
(75) 60 (52) 0.0579
(70) 42 (37) 0.005
(20) 10 (9) 0.1259
(70) 57 (50) 0.0912
(45) 31 (27) 0.1029
(50) 51 (44) 0.6392
(95) 69 (60) 0.0024
(50) 6 (5) 0.0001
(30) 3 (3) 0.0001
(60) 11 (10) 0.0001
10.6 53.6  13.2 0.0001
1.9 2.4  1.4 0.0008
disease; MI  myocardial infarction; PCI  percutaneous
emonstrate the ability to detect ischemia in the absence of infarction and
rior coronary artery disease (CAD), no evidence of myocardial infarction (MI),
arizes results from a 56-year-old female with a history of coronary artery bypasserse
(n 
15
14
4
14
9
10
19
10
6
12
68.1 
4.1 dies d
no p
umm
arrow), and a more extensive inferior to inferolateral perfusion defect (white
ion. DE  delayed enhancement; Perf  perfusion.
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Prognostic Value of Negative Adenosine CMR April 4, 2006:1427–32Fourteen patients had abnormal gadolinium delayed en-
ancement studies. The mean infarct size was 19  16 g,
nd 6 of the 14 infarcts were 10 g. Whereas 8 of these 14
atients had a prior clinical history of MI, 6 subjects had
linically unrecognized MI that ranged in size from 2 to 43 g.
The sensitivity, specificity, positive predictive value, and
egative predictive value of a regional wall motion abnor-
ality, delayed enhancement, abnormal adenosine perfu-
ion, and any CMR abnormality in predicting an adverse
utcome are given in Table 2. Delayed enhancement indic-
tive of MI had a sensitivity of only 55%, and a regional wall
otion abnormality had a sensitivity of 70%. However, both
echniques had high specificity. Adenosine perfusion abnor-
alities had 100% sensitivity and 93% specificity as the
ingle most accurate component of the CMR examination.
ombining all CMR results to label a CMR study as
ormal or abnormal only reduced specificity to 91%. In
omparison, total cardiac risk factors 3 versus 3 as a
redictor of adverse outcome had a sensitivity of 65% and a
pecificity of 76%.
rognosis. Of 135 patients enrolled, 20 experienced ad-
erse outcomes before the end of the study; the remainder
ere considered censored at the date of last follow-up in the
aplan-Meier analysis. Figure 2 illustrates the estimated
ime to event distribution for patients based on any CMR
bnormalities. The separation in the survival distributions
or those with any CMR abnormality and those without was
ighly significant (p  0.0001). The estimated survival
istribution for total cardiac risk factors (TLCRF []
efined as 3 risk factors vs. TLCRF [] defined as 3
isk factors) using the Kaplan-Meier method had less
eparation but was significant (log-rank test, p  0.0006).
A Cox proportional hazards regression model on TLCRF
howed increasing TLCRF to be a significant negative
rognostic factor for future adverse cardiac outcome (like-
ihood ratio chi-square  19.22, p  0.0001) with a hazard
atio of 1.908 (95% confidence interval 1.405 to 2.592),
ndicating almost a doubling of risk for each additional risk
actor. When modeled singly, an abnormal CMR study was
significant negative prognostic factor (likelihood ratio
hi-square  67.47, p  0.0001) with a hazard ratio of
07.33 (95% confidence interval 28.43 to 26,397). When
LCRF and an abnormal CMR were modeled together,
nly an abnormal CMR was significant.
The estimated receiver operating characteristic curves for
Table 2. Diagnostic Performance of Individual
Cardiac Outcome
Resting RWM
(n  19)
Adenosine Pe
(n  28
Sensitivity (%) 70 100
Specificity (%) 96 93
PPV (%) 74 71
NPV (%) 95 100
CMR  cardiac magnetic resonance; NPV  negative predic
motion.LCRF and TLCMR are given in Figure 3. The estimated
w
erea under the curve was 0.758 for TLCRF and 0.973 for
LCMR. The observed difference in areas was significant
chi-square 10.14, p  0.002), demonstrating that the aden-
sine CMR was a more accurate predictor of adverse outcome
han the total number of cardiac risk factors.
ISCUSSION
n our study, patients with a normal adenosine stress CMR
can had an excellent prognosis as none of the subjects was
iagnosed with an adverse event during one-year follow-up.
R Components in Detecting Future Adverse
n Delayed Enhancement
(n  14)
Any Abnormality
(n  30)
55 100
97 91
79 67
93 100
lue; PPV  positive predictive value; RWM  regional wall
igure 2. Kaplan-Meier survival distributions based on presence or absence of
ny abnormalities on the cardiac magnetic resonance (CMR) and 3 versus
3 total cardiac risk factors (TLCRF). Although the separation is statistically
ignificant for each curve, note that a normal adenosine perfusion has 100%
vent-free survival (100% negative predictive value) whereas 35% of subjectsCM
rfusio
)ith 3 TLCRF missed 35% of patients with an outcome dropping
vent-free survival in that group. CAD  coronary artery disease.
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April 4, 2006:1427–32 Prognostic Value of Negative Adenosine CMRonversely, the specificity of an abnormal adenosine CMR
as high. Furthermore, all but four of the abnormal
denosine perfusion abnormalities without cardiovascular
vents in follow-up were explainable on the basis of old
nfarctions, a situation that should not be considered a false
ositive. Thus, the adenosine stress CMR study not only
eparates the prognosis of patients as shown in the Kaplan-
eier analysis but also has the sensitivity to reassure the
hysician that important coronary disease is not missed.
hese results are striking in that the pretest probability of
isease was 15%, as expected for patients with normal
roponin levels, normal average ejection fractions, and an
CG not diagnostic of ischemia or infarction (17,18).
Prognosis studies using CMR are still limited in num-
ers. In a study of 279 patients deemed ineligible for stress
chocardiogram because of poor endocardial visualization,
undley et al. (18) found that dobutamine/atropine CMR
ad prognostic value. In that study, left ventricular ejection
raction was a powerful prognosticator, but the presence or
bsence of ischemia modulated these findings significantly.
The current study prognosticates the one-year likelihood
f a patient having important coronary disease or adverse
ardiac outcomes. Thus, the reference for correct diagnosis
s determined by long-term follow-up. It is possible that
ome patients may have had an intermediate coronary
tenosis that was missed. In our study, the absence of
dverse long-term outcomes in those patients with normal
tudies suggests that any missed stenoses were not contrib-
ting to the etiology of the chest pain or did not need
ntervention at the time of the CMR scan. Thus, the CMR
can could fit within current American Heart Association/
merican College of Cardiology clinical practice guidelines
igure 3. Estimated receiver operating characteristic curve for total number of
ardiac risk factors (TLCRF) (triangles) and receiver operating characteristic
urve for total number of abnormalities on adenosine cardiac magnetic
esonance (TLCMR) as a predictors of adverse cardiac outcome (circles).or the management of possible or probable acute coronary byndrome, in which a stress test is recommended in subjects
ho have MI excluded by serial ECGs and blood tests.
It is not likely that many significant coronary stenoses
ere missed, because CMR perfusion scans perform as well
s or better than current clinical perfusion tests. The
ensitivity of subendocardial defects on a CMR study is
quivalent to a positron emission tomography scan for
etection of coronary stenosis defined by quantitative cor-
nary angiography (19). Using very similar methodologies
o those described in the current study, Ishida et al. (20)
eported sensitivities of 85%, 96%, and 100% in detecting
ingle-, double-, and triple-vessel disease with a specificity
f 85% in 104 patients who underwent coronary angiogra-
hy. In that same study, stress perfusion single photon
mission computed tomography had a sensitivity and spec-
ficity of 64% and 79% in depicting stenosis in individual
oronary arteries. Al-Saadi et al. (21) have reported sensi-
ivities of 90% in detecting significant coronary stenoses,
sing semiquantitative analysis of CMR perfusion. Finally,
lein et al. (22) found that adenosine perfusion and coro-
ary angiography are the two most sensitive components of
comprehensive CMR examination performed in patients
ith acute coronary syndrome undergoing clinically indi-
ated coronary angiography.
The advent of multi-slice detector computed tomography
s also promising in the rapid detection of significant
natomic CAD. In 59 patients, Leber et al. (23) demon-
trated that 64-slice computed tomography had a sensitivity
f 80% in detecting stenoses75% and a specificity of 97%.
aff et al. reported a sensitivity and specificity of 91% and
2% in the detection of significant disease (50%) on a per
rtery basis in 70 patients (24). Mollet et al. (25) reported a
ensitivity and specificity of 99% and 95% for detecting
ignificant stenoses (50%) in 52 patients. Christian re-
ently pointed out that physiological stress testing provides
dditional prognostic value beyond known coronary anat-
my (26). Thus, stress testing and viability assessment may
rovide more complementary information to the catheter-
zation laboratory where the coronary anatomy ultimately
ill be definitively defined.
The current study is substantially different from prior
ork by Kwong et al. (4). In patients very early after
resentation to an emergency department, a rest CMR scan
ad high sensitivity and specificity for acute coronary
yndrome. In that study, regional wall motion abnormali-
ies, particularly in the absence of infarction, were strong
vidence of recent myocardial ischemia and thus a diagnosis
f acute coronary syndrome. In the present study, patients
nderwent the adenosine CMR scan within 72 h of pre-
entation to the emergency department with chest discom-
ort. Regional stunning that might have occurred with an
schemic chest discomfort episode could have resolved by
he time of our imaging. However, the current approach has
he power to detect significant coronary stenoses that might
e missed on a rest study.
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Prognostic Value of Negative Adenosine CMR April 4, 2006:1427–32The relative insensitivity of the delayed enhancement
tudy should not be surprising. By definition, patients in this
tudy had acute MI excluded by serial ECG and troponin
ssays. However, abnormal delayed enhancement had prog-
ostic significance despite the fact that 43% of infarcts were
10 g. It is also of interest that 6 of the 14 cases of delayed
nhancement represented clinically unrecognized MIs.
Concerning the safety of adenosine testing in a CMR
canner, all scanning was performed with a technologist
canning the patient, a nurse administering the adenosine
nd monitoring vital signs, and a physician interpreting the
tudy, as well as providing additional medical supervision.
here were no major adverse sequelae related to adminis-
ration of adenosine. Overall, vasodilator stress testing is less
ikely to precipitate serious adverse events than dobutamine
tress testing (27).
onclusions. In patients with chest pain who have had MI
xcluded by serial cardiac enzymes and at least 6 h of
bservation, an adenosine CMR examination demonstrated
high sensitivity and specificity in the prediction of a CAD
iagnosis and adverse cardiovascular end points at one year.
n these low-risk patients, the adenosine perfusion images
erformed better than rest cine function or delayed en-
ancement. A normal adenosine CMR examination was
ssociated with no diagnosis of CAD on follow-up and no
dverse cardiovascular outcomes.
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